This invention provides a system of providing and a process of creating personalized immunotherapeutic compositions for a subject having a disease or condition including therapeutic vaccine delivery vectors comprising gene expression constructs expressing peptides associated with one or more neo epitopes or peptides containing mutations that are specific to an subjects cancer or unhealthy tissue. The invention further provides a scalable fully enclosed single use cell growth system wherein the entire process of manufacturing of personalized immunotherapeutic compositions up to and including dispensing said composition into containers for patient delivery is carried out within a single enclosed fluid flow path.
